| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ethanol | 34 | 2023 | 1331 | 3.640 |
Why?
|
| Neural Cell Adhesion Molecule L1 | 9 | 2018 | 44 | 2.030 |
Why?
|
| Cell Adhesion | 18 | 2019 | 3096 | 1.550 |
Why?
|
| Central Nervous System Depressants | 5 | 2018 | 163 | 0.980 |
Why?
|
| Ankyrins | 2 | 2019 | 123 | 0.800 |
Why?
|
| Lactams | 1 | 2022 | 159 | 0.770 |
Why?
|
| Leucine | 1 | 2022 | 547 | 0.730 |
Why?
|
| Proline | 1 | 2022 | 455 | 0.720 |
Why?
|
| Ritonavir | 1 | 2022 | 331 | 0.710 |
Why?
|
| Telemedicine | 6 | 2024 | 3109 | 0.700 |
Why?
|
| Alcohol-Related Disorders | 1 | 2022 | 243 | 0.650 |
Why?
|
| Dystonic Disorders | 4 | 2013 | 354 | 0.650 |
Why?
|
| Alcoholism | 7 | 2022 | 1980 | 0.640 |
Why?
|
| Adolescent Development | 2 | 2019 | 276 | 0.590 |
Why?
|
| Oligopeptides | 7 | 2011 | 1194 | 0.560 |
Why?
|
| Nitriles | 1 | 2022 | 980 | 0.560 |
Why?
|
| Nasopharynx | 1 | 2020 | 420 | 0.560 |
Why?
|
| Prenatal Exposure Delayed Effects | 6 | 2023 | 2538 | 0.470 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2020 | 789 | 0.460 |
Why?
|
| Health Personnel | 4 | 2023 | 3385 | 0.460 |
Why?
|
| Occupational Diseases | 3 | 2021 | 1457 | 0.460 |
Why?
|
| Transforming Growth Factor beta | 7 | 2000 | 1996 | 0.440 |
Why?
|
| Music | 4 | 2004 | 247 | 0.440 |
Why?
|
| Membrane Microdomains | 1 | 2014 | 205 | 0.430 |
Why?
|
| Advisory Committees | 1 | 2017 | 797 | 0.430 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 1 | 2012 | 66 | 0.410 |
Why?
|
| 1-Octanol | 2 | 2002 | 7 | 0.410 |
Why?
|
| Neural Cell Adhesion Molecules | 5 | 2001 | 122 | 0.400 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 4 | 1994 | 263 | 0.390 |
Why?
|
| Bone Morphogenetic Proteins | 7 | 2000 | 845 | 0.390 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2013 | 478 | 0.370 |
Why?
|
| Attitude of Health Personnel | 2 | 2023 | 3929 | 0.360 |
Why?
|
| Alcohol Drinking | 6 | 2023 | 4045 | 0.350 |
Why?
|
| Antiviral Agents | 1 | 2022 | 3073 | 0.340 |
Why?
|
| src-Family Kinases | 1 | 2012 | 539 | 0.340 |
Why?
|
| Nerve Growth Factors | 1 | 2012 | 564 | 0.330 |
Why?
|
| NIH 3T3 Cells | 5 | 2018 | 669 | 0.330 |
Why?
|
| Neurons | 9 | 2012 | 9514 | 0.320 |
Why?
|
| Alcohols | 4 | 2007 | 94 | 0.310 |
Why?
|
| National Institute on Alcohol Abuse and Alcoholism (U.S.) | 2 | 2022 | 10 | 0.300 |
Why?
|
| Thalamus | 1 | 2013 | 1047 | 0.280 |
Why?
|
| Axons | 2 | 2012 | 1677 | 0.280 |
Why?
|
| Homeodomain Proteins | 2 | 2008 | 2429 | 0.270 |
Why?
|
| Wernicke Encephalopathy | 3 | 1999 | 29 | 0.270 |
Why?
|
| Brain | 8 | 2019 | 27360 | 0.250 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 2000 | 580 | 0.250 |
Why?
|
| Nerve Tissue Proteins | 3 | 2008 | 4413 | 0.240 |
Why?
|
| 3T3 Cells | 6 | 2004 | 1084 | 0.240 |
Why?
|
| Dystonia | 4 | 1997 | 378 | 0.240 |
Why?
|
| Teratogens | 3 | 2001 | 119 | 0.240 |
Why?
|
| Leukocyte L1 Antigen Complex | 7 | 2001 | 93 | 0.230 |
Why?
|
| Biomedical Research | 2 | 2018 | 3463 | 0.230 |
Why?
|
| Aerosols | 2 | 2024 | 634 | 0.230 |
Why?
|
| Cross Infection | 2 | 2024 | 1426 | 0.220 |
Why?
|
| Air Microbiology | 1 | 2024 | 95 | 0.220 |
Why?
|
| Pregnancy | 14 | 2023 | 30256 | 0.210 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2012 | 2810 | 0.200 |
Why?
|
| Proteins | 5 | 1995 | 6009 | 0.200 |
Why?
|
| Embryo, Mammalian | 3 | 2004 | 1676 | 0.200 |
Why?
|
| Receptors, Opioid | 3 | 1989 | 145 | 0.200 |
Why?
|
| Humans | 68 | 2024 | 768166 | 0.190 |
Why?
|
| Bone Morphogenetic Protein 7 | 6 | 2000 | 110 | 0.190 |
Why?
|
| Residential Facilities | 1 | 2021 | 41 | 0.190 |
Why?
|
| Abnormalities, Drug-Induced | 2 | 2006 | 337 | 0.190 |
Why?
|
| Crk-Associated Substrate Protein | 2 | 2012 | 39 | 0.180 |
Why?
|
| Genes, fos | 1 | 2000 | 176 | 0.170 |
Why?
|
| Animals | 42 | 2020 | 169246 | 0.170 |
Why?
|
| Korsakoff Syndrome | 1 | 1999 | 18 | 0.170 |
Why?
|
| Genome, Viral | 1 | 2024 | 674 | 0.170 |
Why?
|
| Mice | 24 | 2020 | 82029 | 0.170 |
Why?
|
| Cognition | 1 | 2017 | 7073 | 0.170 |
Why?
|
| Neuroprotective Agents | 2 | 2005 | 958 | 0.170 |
Why?
|
| United States Department of Veterans Affairs | 2 | 2021 | 937 | 0.160 |
Why?
|
| Cerebellum | 3 | 2012 | 1522 | 0.160 |
Why?
|
| Ulnar Nerve | 2 | 1996 | 104 | 0.160 |
Why?
|
| 1-Butanol | 2 | 2011 | 13 | 0.150 |
Why?
|
| Spectrin | 1 | 2018 | 176 | 0.140 |
Why?
|
| Dissociative Disorders | 1 | 2019 | 235 | 0.140 |
Why?
|
| Mental Health | 2 | 2022 | 3275 | 0.140 |
Why?
|
| Structure-Activity Relationship | 4 | 2004 | 3055 | 0.140 |
Why?
|
| Cell Line | 9 | 2014 | 15597 | 0.140 |
Why?
|
| Rats | 15 | 2012 | 23760 | 0.140 |
Why?
|
| Specialties, Surgical | 1 | 2021 | 391 | 0.130 |
Why?
|
| Brain Mapping | 2 | 2019 | 6685 | 0.130 |
Why?
|
| Drug Combinations | 1 | 2022 | 2089 | 0.130 |
Why?
|
| Molecular Chaperones | 1 | 2000 | 762 | 0.130 |
Why?
|
| Receptors, Opioid, delta | 2 | 1993 | 48 | 0.130 |
Why?
|
| Specimen Handling | 1 | 2020 | 708 | 0.120 |
Why?
|
| Supraoptic Nucleus | 1 | 1995 | 28 | 0.120 |
Why?
|
| Peptides | 3 | 2019 | 4354 | 0.120 |
Why?
|
| Delivery of Health Care | 2 | 2024 | 5367 | 0.120 |
Why?
|
| Receptors, Adrenergic, alpha | 2 | 1993 | 146 | 0.120 |
Why?
|
| Peptide Fragments | 2 | 2007 | 5151 | 0.120 |
Why?
|
| Eye Abnormalities | 2 | 2007 | 243 | 0.120 |
Why?
|
| Phosphorylation | 4 | 2018 | 8317 | 0.110 |
Why?
|
| Infection Control | 1 | 2021 | 985 | 0.110 |
Why?
|
| Electric Injuries | 1 | 1994 | 24 | 0.110 |
Why?
|
| Fingers | 2 | 1996 | 511 | 0.110 |
Why?
|
| Supranuclear Palsy, Progressive | 1 | 1994 | 82 | 0.110 |
Why?
|
| Ophthalmoplegia | 2 | 1992 | 168 | 0.110 |
Why?
|
| Basal Ganglia Diseases | 1 | 1994 | 145 | 0.110 |
Why?
|
| Receptors, Muscarinic | 1 | 1993 | 157 | 0.110 |
Why?
|
| Wakefulness | 1 | 2000 | 1284 | 0.110 |
Why?
|
| Amino Acid Substitution | 2 | 2011 | 1743 | 0.110 |
Why?
|
| Gene Deletion | 1 | 2000 | 2675 | 0.100 |
Why?
|
| Sodium Chloride | 1 | 1995 | 584 | 0.100 |
Why?
|
| Ocular Motility Disorders | 1 | 1994 | 144 | 0.100 |
Why?
|
| Pandemics | 2 | 2023 | 8748 | 0.100 |
Why?
|
| Cell Aggregation | 1 | 1992 | 238 | 0.100 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 1995 | 500 | 0.100 |
Why?
|
| Cell Differentiation | 2 | 2008 | 11669 | 0.100 |
Why?
|
| Leg Injuries | 1 | 1994 | 180 | 0.100 |
Why?
|
| Cells, Cultured | 6 | 2012 | 19015 | 0.100 |
Why?
|
| Female | 28 | 2023 | 397192 | 0.100 |
Why?
|
| Brain Damage, Chronic | 1 | 1993 | 265 | 0.100 |
Why?
|
| History, 21st Century | 1 | 2018 | 1573 | 0.100 |
Why?
|
| Mental Health Services | 1 | 2023 | 1732 | 0.100 |
Why?
|
| National Institute on Drug Abuse (U.S.) | 1 | 2011 | 11 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 8 | 2018 | 22379 | 0.090 |
Why?
|
| Membrane Glycoproteins | 3 | 2001 | 3711 | 0.090 |
Why?
|
| Massachusetts | 2 | 2021 | 8890 | 0.090 |
Why?
|
| Mercaptoethanol | 1 | 2011 | 61 | 0.090 |
Why?
|
| Fatty Alcohols | 1 | 2011 | 22 | 0.090 |
Why?
|
| Hand Injuries | 1 | 1994 | 239 | 0.090 |
Why?
|
| GTP-Binding Proteins | 3 | 1993 | 948 | 0.090 |
Why?
|
| Retinal Artery Occlusion | 1 | 1991 | 83 | 0.090 |
Why?
|
| History, 20th Century | 2 | 2018 | 2766 | 0.090 |
Why?
|
| Chickens | 1 | 2012 | 845 | 0.090 |
Why?
|
| Nitroglycerin | 1 | 1991 | 332 | 0.090 |
Why?
|
| Blepharoptosis | 1 | 1991 | 144 | 0.090 |
Why?
|
| Signal Transduction | 5 | 2018 | 23645 | 0.090 |
Why?
|
| Animals, Newborn | 2 | 2012 | 2678 | 0.080 |
Why?
|
| Recurrence | 1 | 2022 | 8509 | 0.080 |
Why?
|
| Nervous System Diseases | 3 | 1998 | 1662 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 8 | 2007 | 10760 | 0.080 |
Why?
|
| Social Environment | 1 | 2014 | 1012 | 0.080 |
Why?
|
| Vaccination | 1 | 2021 | 3437 | 0.080 |
Why?
|
| Social Stigma | 1 | 2016 | 788 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 2008 | 114 | 0.080 |
Why?
|
| Calcium-Binding Proteins | 1 | 1993 | 1083 | 0.080 |
Why?
|
| Survival Analysis | 1 | 2021 | 10101 | 0.080 |
Why?
|
| Disease Management | 1 | 2019 | 2536 | 0.080 |
Why?
|
| United States | 6 | 2022 | 73039 | 0.080 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2022 | 3231 | 0.080 |
Why?
|
| Butanols | 1 | 2007 | 19 | 0.080 |
Why?
|
| Mutation, Missense | 2 | 2011 | 2592 | 0.080 |
Why?
|
| Fibroblasts | 1 | 1998 | 4176 | 0.070 |
Why?
|
| Veterans | 1 | 2022 | 2669 | 0.070 |
Why?
|
| Incidence | 4 | 2021 | 21538 | 0.070 |
Why?
|
| Diazomethane | 1 | 2007 | 37 | 0.070 |
Why?
|
| Enzyme Activation | 2 | 2012 | 3590 | 0.070 |
Why?
|
| Spinal Cord Diseases | 1 | 1990 | 291 | 0.070 |
Why?
|
| Carrier Proteins | 1 | 2000 | 4937 | 0.070 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2011 | 794 | 0.070 |
Why?
|
| Alcoholic Intoxication | 2 | 1989 | 171 | 0.070 |
Why?
|
| Giant Cell Arteritis | 1 | 1991 | 307 | 0.070 |
Why?
|
| Time Factors | 6 | 2024 | 40218 | 0.070 |
Why?
|
| Gene Expression Regulation | 3 | 2011 | 11928 | 0.070 |
Why?
|
| Maternal Exposure | 1 | 2014 | 1096 | 0.070 |
Why?
|
| Muscle Cramp | 2 | 1997 | 33 | 0.070 |
Why?
|
| Male | 26 | 2024 | 364719 | 0.070 |
Why?
|
| Cerebral Infarction | 1 | 1991 | 969 | 0.070 |
Why?
|
| Proportional Hazards Models | 1 | 2021 | 12543 | 0.070 |
Why?
|
| Cysteine | 1 | 2011 | 897 | 0.060 |
Why?
|
| Mass Screening | 1 | 2021 | 5458 | 0.060 |
Why?
|
| Calcinosis | 1 | 1994 | 1481 | 0.060 |
Why?
|
| Apoptosis | 1 | 2001 | 9523 | 0.060 |
Why?
|
| Binding Sites | 3 | 2011 | 6020 | 0.060 |
Why?
|
| Sleep | 2 | 2000 | 4819 | 0.060 |
Why?
|
| Prevalence | 2 | 2019 | 15869 | 0.060 |
Why?
|
| Hybridomas | 1 | 1986 | 444 | 0.060 |
Why?
|
| Oxidation-Reduction | 1 | 2011 | 2227 | 0.060 |
Why?
|
| Primary Health Care | 1 | 2021 | 4746 | 0.060 |
Why?
|
| Middle Aged | 13 | 2024 | 223492 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2013 | 6229 | 0.060 |
Why?
|
| Gene Knockdown Techniques | 1 | 2008 | 1606 | 0.060 |
Why?
|
| Cross-Sectional Studies | 2 | 2023 | 26379 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 1 | 2011 | 3772 | 0.060 |
Why?
|
| Botulinum Toxins | 2 | 1997 | 191 | 0.060 |
Why?
|
| Risk | 1 | 2016 | 9613 | 0.060 |
Why?
|
| Benzofurans | 1 | 1984 | 138 | 0.050 |
Why?
|
| NADH Dehydrogenase | 1 | 2003 | 47 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2023 | 41754 | 0.050 |
Why?
|
| Functional Laterality | 2 | 2004 | 2264 | 0.050 |
Why?
|
| Prazosin | 2 | 1979 | 95 | 0.050 |
Why?
|
| Hypothalamus | 2 | 1987 | 1004 | 0.050 |
Why?
|
| Receptors, Adrenergic | 3 | 1978 | 155 | 0.050 |
Why?
|
| Neural Tube Defects | 1 | 2005 | 255 | 0.050 |
Why?
|
| Amiodarone | 1 | 1984 | 217 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2019 | 9015 | 0.050 |
Why?
|
| Tetrodotoxin | 1 | 2003 | 243 | 0.050 |
Why?
|
| Dementia | 1 | 1996 | 2740 | 0.050 |
Why?
|
| Kinetics | 3 | 1995 | 6329 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2012 | 3728 | 0.050 |
Why?
|
| Cyclic AMP | 3 | 1993 | 1470 | 0.050 |
Why?
|
| Brain Ischemia | 1 | 1995 | 3007 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 3 | 1994 | 6124 | 0.050 |
Why?
|
| Adult | 16 | 2023 | 223646 | 0.050 |
Why?
|
| Cell Adhesion Molecules | 1 | 2007 | 1613 | 0.050 |
Why?
|
| Videoconferencing | 1 | 2023 | 209 | 0.050 |
Why?
|
| Organ Culture Techniques | 1 | 2003 | 794 | 0.050 |
Why?
|
| Diprenorphine | 2 | 1993 | 13 | 0.050 |
Why?
|
| Pindolol | 2 | 1977 | 34 | 0.040 |
Why?
|
| Pyrimidines | 1 | 2012 | 3048 | 0.040 |
Why?
|
| Tissue Distribution | 2 | 1995 | 2300 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2003 | 1683 | 0.040 |
Why?
|
| Neural Inhibition | 1 | 2004 | 588 | 0.040 |
Why?
|
| Telephone | 1 | 2023 | 630 | 0.040 |
Why?
|
| Neuroblastoma | 4 | 1992 | 1266 | 0.040 |
Why?
|
| Peripheral Nervous System Diseases | 2 | 1996 | 716 | 0.040 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2005 | 903 | 0.040 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 1984 | 628 | 0.040 |
Why?
|
| Thiamine | 1 | 1999 | 160 | 0.040 |
Why?
|
| RNA, Messenger | 4 | 2011 | 12800 | 0.040 |
Why?
|
| Adolescent | 5 | 2019 | 89169 | 0.040 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2018 | 55 | 0.040 |
Why?
|
| Carrier State | 1 | 2021 | 529 | 0.040 |
Why?
|
| Phenylisopropyladenosine | 2 | 1988 | 14 | 0.040 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 1990 | 2171 | 0.040 |
Why?
|
| Electromyography | 2 | 2000 | 1401 | 0.040 |
Why?
|
| DNA, Mitochondrial | 1 | 2003 | 872 | 0.040 |
Why?
|
| Obesity | 1 | 2020 | 13090 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2019 | 36743 | 0.040 |
Why?
|
| Hypokalemia | 1 | 1978 | 152 | 0.040 |
Why?
|
| Internationality | 1 | 2003 | 1008 | 0.030 |
Why?
|
| Body Temperature | 1 | 2000 | 780 | 0.030 |
Why?
|
| Paralysis | 1 | 1978 | 250 | 0.030 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 1998 | 446 | 0.030 |
Why?
|
| Drug Interactions | 1 | 2001 | 1419 | 0.030 |
Why?
|
| Sampling Studies | 1 | 2018 | 615 | 0.030 |
Why?
|
| Acetaldehyde | 1 | 1996 | 39 | 0.030 |
Why?
|
| Electroencephalography | 2 | 2004 | 6314 | 0.030 |
Why?
|
| Cell Division | 2 | 1994 | 4473 | 0.030 |
Why?
|
| Behavior | 2 | 1979 | 542 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2011 | 8128 | 0.030 |
Why?
|
| Isoproterenol | 1 | 1976 | 398 | 0.030 |
Why?
|
| Metalloendopeptidases | 1 | 1998 | 386 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 12252 | 0.030 |
Why?
|
| Quinazolines | 2 | 1979 | 1373 | 0.030 |
Why?
|
| Ambulatory Care Facilities | 1 | 2022 | 939 | 0.030 |
Why?
|
| Neurotransmitter Agents | 2 | 1996 | 663 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2000 | 1883 | 0.030 |
Why?
|
| Cooperative Behavior | 1 | 2003 | 1514 | 0.030 |
Why?
|
| Dystonia Musculorum Deformans | 1 | 1996 | 158 | 0.030 |
Why?
|
| Angina Pectoris | 1 | 1979 | 957 | 0.030 |
Why?
|
| Immunoblotting | 1 | 1998 | 1647 | 0.030 |
Why?
|
| Cerebellar Cortex | 1 | 1996 | 108 | 0.030 |
Why?
|
| Neuronal Plasticity | 1 | 2004 | 1448 | 0.030 |
Why?
|
| Intra-Abdominal Fat | 1 | 2020 | 625 | 0.030 |
Why?
|
| Acetates | 1 | 1996 | 317 | 0.030 |
Why?
|
| Stereotyped Behavior | 1 | 1975 | 133 | 0.030 |
Why?
|
| Saline Solution, Hypertonic | 1 | 1995 | 115 | 0.030 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 1996 | 481 | 0.030 |
Why?
|
| Learning | 1 | 2004 | 1759 | 0.030 |
Why?
|
| Jews | 1 | 1996 | 359 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 1996 | 534 | 0.030 |
Why?
|
| Maternal Behavior | 1 | 2016 | 307 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 18065 | 0.030 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1993 | 154 | 0.030 |
Why?
|
| Reflex Sympathetic Dystrophy | 1 | 1994 | 60 | 0.030 |
Why?
|
| Consensus | 1 | 2024 | 3212 | 0.030 |
Why?
|
| Pertussis Toxin | 1 | 1993 | 176 | 0.030 |
Why?
|
| Potassium Channels | 1 | 1996 | 538 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2022 | 2872 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2004 | 3780 | 0.030 |
Why?
|
| Sleep Deprivation | 1 | 2000 | 848 | 0.030 |
Why?
|
| Alcohol Amnestic Disorder | 1 | 1993 | 35 | 0.030 |
Why?
|
| Olivopontocerebellar Atrophies | 1 | 1993 | 19 | 0.030 |
Why?
|
| Blotting, Northern | 1 | 1995 | 1550 | 0.030 |
Why?
|
| Electrophysiology | 1 | 1996 | 1266 | 0.030 |
Why?
|
| Eponyms | 1 | 1992 | 14 | 0.030 |
Why?
|
| Mesencephalon | 2 | 1992 | 338 | 0.030 |
Why?
|
| Drug Resistance | 1 | 1998 | 1599 | 0.030 |
Why?
|
| Disease Outbreaks | 1 | 2022 | 1761 | 0.030 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1993 | 826 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2021 | 81762 | 0.020 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2019 | 1489 | 0.020 |
Why?
|
| Movement | 2 | 1996 | 1490 | 0.020 |
Why?
|
| Hippocampus | 1 | 2005 | 3785 | 0.020 |
Why?
|
| Brain Injuries | 1 | 2004 | 2057 | 0.020 |
Why?
|
| Injections | 1 | 1995 | 840 | 0.020 |
Why?
|
| Lyme Disease | 1 | 1998 | 630 | 0.020 |
Why?
|
| Hepatic Encephalopathy | 1 | 1993 | 144 | 0.020 |
Why?
|
| Neurites | 1 | 1993 | 389 | 0.020 |
Why?
|
| Growth Substances | 1 | 1994 | 759 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2000 | 6231 | 0.020 |
Why?
|
| Blood | 1 | 1994 | 599 | 0.020 |
Why?
|
| Psychiatry | 1 | 2023 | 1716 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 1996 | 1394 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2002 | 13421 | 0.020 |
Why?
|
| Cerebellar Diseases | 1 | 1993 | 227 | 0.020 |
Why?
|
| Rats, Long-Evans | 1 | 2011 | 380 | 0.020 |
Why?
|
| Eye Movements | 1 | 1994 | 514 | 0.020 |
Why?
|
| Multigene Family | 1 | 1994 | 1081 | 0.020 |
Why?
|
| Education, Graduate | 1 | 2011 | 75 | 0.020 |
Why?
|
| Morphine | 1 | 1975 | 658 | 0.020 |
Why?
|
| Molecular Weight | 1 | 1992 | 2173 | 0.020 |
Why?
|
| Physical Examination | 1 | 2016 | 1263 | 0.020 |
Why?
|
| Morphogenesis | 1 | 1994 | 746 | 0.020 |
Why?
|
| Peripheral Nerves | 1 | 1994 | 490 | 0.020 |
Why?
|
| Foot | 1 | 1994 | 576 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 1994 | 1617 | 0.020 |
Why?
|
| Haplotypes | 1 | 1996 | 2722 | 0.020 |
Why?
|
| Physician's Role | 1 | 2016 | 925 | 0.020 |
Why?
|
| Protein Precursors | 1 | 1993 | 1134 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2022 | 3620 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 2 | 1998 | 9263 | 0.020 |
Why?
|
| Brain Diseases | 3 | 1992 | 1554 | 0.020 |
Why?
|
| Hospitals | 1 | 2022 | 3886 | 0.020 |
Why?
|
| Alprostadil | 1 | 1988 | 86 | 0.020 |
Why?
|
| Glioma | 3 | 1992 | 3503 | 0.020 |
Why?
|
| Quality Control | 1 | 2011 | 836 | 0.020 |
Why?
|
| Biological Assay | 1 | 2011 | 628 | 0.020 |
Why?
|
| Zebrafish | 1 | 2020 | 3035 | 0.020 |
Why?
|
| Drug Tolerance | 2 | 1984 | 365 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1992 | 2474 | 0.020 |
Why?
|
| Temperature | 1 | 1995 | 2234 | 0.020 |
Why?
|
| Transfection | 1 | 1996 | 5755 | 0.020 |
Why?
|
| Cattle | 1 | 1994 | 3819 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2020 | 26422 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 1996 | 4620 | 0.020 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2019 | 2815 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 9561 | 0.020 |
Why?
|
| Photochemistry | 1 | 2007 | 238 | 0.020 |
Why?
|
| Hydrogen Bonding | 1 | 2007 | 289 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 2016 | 13014 | 0.020 |
Why?
|
| Mothers | 1 | 2018 | 2209 | 0.020 |
Why?
|
| Policy | 1 | 2011 | 513 | 0.020 |
Why?
|
| Erythrocytes | 1 | 1976 | 2418 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 1975 | 1862 | 0.020 |
Why?
|
| Gastrula | 1 | 2006 | 83 | 0.020 |
Why?
|
| Enkephalin, Leucine-2-Alanine | 1 | 1986 | 9 | 0.020 |
Why?
|
| Etorphine | 1 | 1986 | 3 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 2007 | 540 | 0.020 |
Why?
|
| Enkephalin, Leucine | 1 | 1986 | 16 | 0.020 |
Why?
|
| Child | 4 | 2018 | 80917 | 0.020 |
Why?
|
| Transcription, Genetic | 2 | 1993 | 7608 | 0.020 |
Why?
|
| Efficiency, Organizational | 1 | 2011 | 697 | 0.020 |
Why?
|
| Neurosciences | 1 | 2011 | 383 | 0.020 |
Why?
|
| Cholera Toxin | 1 | 1988 | 562 | 0.020 |
Why?
|
| Disease Models, Animal | 3 | 2006 | 18349 | 0.020 |
Why?
|
| Behavior, Addictive | 1 | 2011 | 428 | 0.020 |
Why?
|
| Dactinomycin | 1 | 1986 | 305 | 0.020 |
Why?
|
| Cycloheximide | 1 | 1986 | 341 | 0.020 |
Why?
|
| Blotting, Western | 1 | 1992 | 5027 | 0.020 |
Why?
|
| Naloxone | 2 | 1986 | 372 | 0.020 |
Why?
|
| Liver | 2 | 2020 | 7577 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2000 | 14488 | 0.010 |
Why?
|
| Clone Cells | 1 | 1988 | 1670 | 0.010 |
Why?
|
| Immunoassay | 1 | 1988 | 746 | 0.010 |
Why?
|
| Up-Regulation | 1 | 1993 | 4146 | 0.010 |
Why?
|
| Embryo Culture Techniques | 1 | 2005 | 84 | 0.010 |
Why?
|
| Enkephalin, Methionine | 1 | 1983 | 26 | 0.010 |
Why?
|
| Cytoprotection | 1 | 2005 | 200 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2018 | 42669 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2018 | 7852 | 0.010 |
Why?
|
| Hybrid Cells | 1 | 1983 | 421 | 0.010 |
Why?
|
| Registries | 1 | 2020 | 8375 | 0.010 |
Why?
|
| Astrocytes | 1 | 2011 | 1350 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2016 | 7140 | 0.010 |
Why?
|
| Long-Term Potentiation | 1 | 2005 | 290 | 0.010 |
Why?
|
| Tremor | 1 | 1984 | 197 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1992 | 6514 | 0.010 |
Why?
|
| Aged | 7 | 2022 | 171504 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2005 | 944 | 0.010 |
Why?
|
| Electron Transport | 1 | 2003 | 211 | 0.010 |
Why?
|
| Eye | 1 | 2006 | 712 | 0.010 |
Why?
|
| Atrophy | 1 | 1987 | 1646 | 0.010 |
Why?
|
| Neutrophils | 1 | 1995 | 3786 | 0.010 |
Why?
|
| Neuropeptides | 1 | 2007 | 951 | 0.010 |
Why?
|
| Ataxia | 1 | 1984 | 307 | 0.010 |
Why?
|
| Narcotics | 1 | 1984 | 332 | 0.010 |
Why?
|
| Light | 1 | 2007 | 1355 | 0.010 |
Why?
|
| Leadership | 1 | 2011 | 1397 | 0.010 |
Why?
|
| Embryonic Development | 1 | 2006 | 724 | 0.010 |
Why?
|
| Quality of Life | 1 | 2023 | 13490 | 0.010 |
Why?
|
| Electric Stimulation | 2 | 2005 | 1741 | 0.010 |
Why?
|
| Pediatrics | 1 | 2016 | 3629 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 14729 | 0.010 |
Why?
|
| Fetal Development | 1 | 2006 | 779 | 0.010 |
Why?
|
| Gene Expression | 1 | 1993 | 7598 | 0.010 |
Why?
|
| Sodium | 1 | 1986 | 1597 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2007 | 2202 | 0.010 |
Why?
|
| Porphyrias | 1 | 1979 | 57 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2003 | 1162 | 0.010 |
Why?
|
| Central Nervous System | 1 | 2006 | 1346 | 0.010 |
Why?
|
| Gelatinases | 1 | 1998 | 93 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2007 | 3447 | 0.010 |
Why?
|
| Collagenases | 1 | 1998 | 221 | 0.010 |
Why?
|
| Periodicity | 1 | 1978 | 348 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 1984 | 1312 | 0.010 |
Why?
|
| Phenylhydrazines | 1 | 1976 | 28 | 0.010 |
Why?
|
| Affective Symptoms | 1 | 1979 | 418 | 0.010 |
Why?
|
| Haloperidol | 2 | 1977 | 394 | 0.010 |
Why?
|
| Receptors, Neurotransmitter | 1 | 1977 | 172 | 0.010 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 1977 | 243 | 0.010 |
Why?
|
| Benzyl Alcohols | 1 | 1976 | 33 | 0.010 |
Why?
|
| Handwriting | 1 | 1996 | 26 | 0.010 |
Why?
|
| Membranes | 1 | 1976 | 164 | 0.010 |
Why?
|
| Comorbidity | 1 | 2011 | 10590 | 0.010 |
Why?
|
| Age of Onset | 1 | 2003 | 3347 | 0.010 |
Why?
|
| Fluorides | 1 | 1976 | 134 | 0.010 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 1998 | 461 | 0.010 |
Why?
|
| Receptors, Drug | 1 | 1975 | 157 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2003 | 1896 | 0.010 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 1998 | 633 | 0.010 |
Why?
|
| Dextroamphetamine | 1 | 1975 | 132 | 0.010 |
Why?
|
| Substance-Related Disorders | 1 | 2011 | 4423 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 1975 | 411 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1984 | 3655 | 0.010 |
Why?
|
| Infant | 1 | 2016 | 36535 | 0.010 |
Why?
|
| Neural Conduction | 1 | 1995 | 443 | 0.010 |
Why?
|
| Dietary Carbohydrates | 1 | 1978 | 896 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 1996 | 855 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 20227 | 0.010 |
Why?
|
| Chromosome Disorders | 1 | 1996 | 498 | 0.010 |
Why?
|
| Aging | 1 | 2011 | 8744 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 1994 | 39348 | 0.010 |
Why?
|
| DNA | 1 | 1986 | 7214 | 0.010 |
Why?
|
| Diazepam | 1 | 1973 | 214 | 0.010 |
Why?
|
| Acute Disease | 2 | 1979 | 7243 | 0.010 |
Why?
|
| Temporal Lobe | 1 | 1979 | 1726 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2003 | 3139 | 0.010 |
Why?
|
| Drinking | 1 | 1973 | 196 | 0.010 |
Why?
|
| Taste | 1 | 1973 | 190 | 0.010 |
Why?
|
| Models, Biological | 1 | 2007 | 9495 | 0.010 |
Why?
|
| Syndrome | 2 | 1992 | 3272 | 0.010 |
Why?
|
| Cerebellar Ataxia | 1 | 1992 | 151 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1994 | 20760 | 0.010 |
Why?
|
| History, 19th Century | 1 | 1992 | 714 | 0.010 |
Why?
|
| Genetic Markers | 1 | 1996 | 2603 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 1996 | 1778 | 0.010 |
Why?
|
| Movement Disorders | 1 | 1992 | 463 | 0.000 |
Why?
|
| Phentolamine | 2 | 1978 | 102 | 0.000 |
Why?
|
| Dopamine | 1 | 1975 | 1592 | 0.000 |
Why?
|
| DNA Mutational Analysis | 1 | 1996 | 4120 | 0.000 |
Why?
|
| Cannabis | 1 | 1973 | 446 | 0.000 |
Why?
|
| Alzheimer Disease | 1 | 1987 | 8759 | 0.000 |
Why?
|
| Polymorphism, Genetic | 1 | 1996 | 4249 | 0.000 |
Why?
|
| Electrocardiography | 1 | 1978 | 6412 | 0.000 |
Why?
|
| Motor Activity | 1 | 1975 | 2711 | 0.000 |
Why?
|
| Blood Pressure | 1 | 1979 | 8543 | 0.000 |
Why?
|
| Circadian Rhythm | 1 | 1975 | 2593 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1998 | 9384 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1987 | 59629 | 0.000 |
Why?
|
| Hypertension | 1 | 1979 | 8616 | 0.000 |
Why?
|
| Dihydroergotoxine | 1 | 1978 | 21 | 0.000 |
Why?
|
| Phenoxybenzamine | 1 | 1978 | 53 | 0.000 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1978 | 170 | 0.000 |
Why?
|
| Phenotype | 1 | 1996 | 16726 | 0.000 |
Why?
|
| Clonidine | 1 | 1978 | 170 | 0.000 |
Why?
|
| Sotalol | 1 | 1977 | 47 | 0.000 |
Why?
|
| Alprenolol | 1 | 1977 | 8 | 0.000 |
Why?
|
| Lysergic Acid Diethylamide | 1 | 1977 | 49 | 0.000 |
Why?
|
| Quinuclidines | 1 | 1977 | 27 | 0.000 |
Why?
|
| Methods | 1 | 1977 | 1066 | 0.000 |
Why?
|
| Choline O-Acetyltransferase | 1 | 1977 | 156 | 0.000 |
Why?
|
| Glutamate Decarboxylase | 1 | 1977 | 239 | 0.000 |
Why?
|
| Propranolol | 1 | 1977 | 493 | 0.000 |
Why?
|
| Heart Failure | 1 | 1979 | 11879 | 0.000 |
Why?
|
| Brain Chemistry | 1 | 1977 | 958 | 0.000 |
Why?
|
| Iodine Radioisotopes | 1 | 1977 | 1034 | 0.000 |
Why?
|
| Solutions | 1 | 1973 | 409 | 0.000 |
Why?
|
| Serotonin | 1 | 1977 | 1043 | 0.000 |
Why?
|
| Osmolar Concentration | 1 | 1973 | 657 | 0.000 |
Why?
|
| Avoidance Learning | 1 | 1973 | 248 | 0.000 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 1977 | 1141 | 0.000 |
Why?
|
| Water | 1 | 1973 | 1421 | 0.000 |
Why?
|
| Myocardium | 1 | 1977 | 4788 | 0.000 |
Why?
|
| Motivation | 1 | 1973 | 2020 | 0.000 |
Why?
|
| Lung | 1 | 1977 | 10099 | 0.000 |
Why?
|